Linda F Van Dyk PhD

  • Integrated Department of Immunology
Gender
Female

Research Interests

Herpesviruses are forever. Gammaherpesviruses persist for a lifetime within cells of the immune system, the very system responsible for their clearance. This balance between the host immune system and viral latency is complex and is dependent on both host and viral genes. The gammaherpesviruses include the human pathogens Epstein Barr virus and Kaposi's sarcoma associated herpesvirus (KSHV), as well as murine gammaherpesvirus 68 (gHV68). Each of these viruses use B lymphocytes as a major reservoir of latency and are associated with B cell malignancies. The focus of my lab is on gammaherpesvirus pathogenesis, particularly on virus and host mechanisms to regulate latency and reactivation. The availability of gHV68 as a murine model of gammaherpesvirus pathogenesis provides the following benefits: 1) a genetically manipulable virus, 2) a genetically manipulable host system with a wealth of genetic alterations and strain variations, and 3) the ability to study pathogen/host interactions over the entire course of viral infection. gHV68 and KSHV both encode homologs of the host cyclins. Exogenous expression of the viral cyclins promotes cell cycle progression and leads to cellular transformation. Infection of normal mice with a mutant gHV68 deficient in viral cyclin expression (v-cyclin KO) results in a profound defect in reactivation from latency. Infection of B cell-deficient mice with this v-cyclin KO results in failure to maintain lifelong latency (the hallmark of herpesviruses). The mechanism of viral cyclin action in maintenance and reactivation from latency is being investigated by use of in vivo complementation and molecular biological studies. The gammaherpesviruses establish latency in B lymphocytes, and virally transformed cells demonstrate altered B cell signaling. It is thought that this ability to derail B cell signaling is important to establishment of latency and evasion of host immune detection. The role of host B cell signaling in establishment of latency is being investigated by infection of mice and cell lines deficient in particular B cell signaling components.

Education & Training

Education

University of Texas Southwestern Medical Center
PhD

Recent or Important Publications

Van Dyk, L. F., Virgin, H.W. IV, and Speck, S. H. 2003. The Murine Gammaherpesvirus 68 v-Cyclin is Essential for Long-term Maintenance of Viral Latency and Provides Evidence for Cell Type Specific Maintenance Mechanisms. J. Virology 77:5118-5126.

Tibbetts, S. A., Van Dyk, L. F., Speck, S. H., and Virgin, H. W. Virgin IV. 2002. Immune Control of the Number and Reactivation Phenotype of Cells Latently Infected with a Gammaherpesvirus. J. Virology 76:7125-7132.

Gangappa, S., Van Dyk, L.F., Jewett, T.J., Speck, S.H., and Virgin, H.W. IV. 2002. Identification of the in vivo role of a viral bcl-2. J. Exp. Med. 195:1-11.

Van Dyk, L.F., Virgin, H.W.IV, and Speck, S.H. 2000. The Murine Gammaherpesvirus 68 v-Cyclin is a Critical Regulator of Reactivation from Latency. J. Virology 74:7451-7461.

Van Dyk, L.F. Hess, J.L., Katz, J.D., Jacoby, M., Speck, S.H., and Virgin, H.W.IV. 1999. The Murine Gammaherpesvirus 68 v-Cyclin Gene is an Oncogene that Promotes Cell Cycle Progression in Primary Lymphocytes. J. Virology 73:5110-5122.

Appointments


1-800-222-5864

Congratulations to Our 28 "Top Docs"


Twenty-eight physicians at National Jewish Health were named "Top Docs" in the annual ranking by 5280 magazine.
Learn more
.

Personalized Medicine


National Jewish Health is at the forefront of a new era in healthcare - personalized medicine.

Our science is truly transforming the lives of millions. Learn more.

Media Center


In the Media Center, you can find National Jewish Health press releases, newsletters, annual reports and media contacts. Learn more.